Amalie Carnbring Bonde, PhD

Research Scientist

Amalie Carnbring Bonde, PhD, serves as a Research Scientist at Hemab. Prior to joining the company, she worked as an industrial PhD student at Novo Nordisk. She holds a PhD in Molecular Biology from Aarhaus University Denmark.

Meet the Team

Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders

Leadership
Board
Team
Investors
novo holdings
RA Capital
HealthCap
Access Biotechnology
Deep Track Capital
Avoro Ventures
Invus
Rock Springs Capital
Maj Invest Equity

We’re building the ultimate clotting company.